Cerus Corp.
(NASDAQ : CERS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -3.35%522.481.0%$688.19m
DHRDanaher Corp. -3.73%267.670.7%$670.89m
ABTAbbott Laboratories -1.14%101.290.8%$566.68m
MDTMedtronic Plc -2.77%82.080.6%$537.25m
ISRGIntuitive Surgical, Inc. -4.66%188.490.8%$345.21m
SYKStryker Corp. -1.87%207.461.3%$303.03m
BSXBoston Scientific Corp. -1.91%39.881.0%$259.91m
BDXBecton, Dickinson & Co. -2.59%222.481.0%$257.69m
DXCMDexCom, Inc. 7.15%102.021.9%$246.17m
EWEdwards Lifesciences Corp. -2.90%83.970.4%$236.16m
ALGNAlign Technology, Inc. -4.79%211.706.4%$201.00m
AAgilent Technologies, Inc. -3.76%127.211.7%$189.27m
BAXBaxter International, Inc. -1.73%55.281.8%$167.00m
STESTERIS Plc (Ireland) -1.73%169.763.1%$145.63m
MTDMettler-Toledo International, Inc. -3.47%1161.475.9%$134.89m

Company Profile

Cerus Corp. engages in the research, development, and manufacturing of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.